FRDRX
Price
$89.32
Change
-$7.48 (-7.73%)
Updated
Dec 20 closing price
VFINX
Price
$548.83
Change
+$5.93 (+1.09%)
Updated
Dec 20 closing price
Ad is loading...

FRDRX vs VFINX

Header iconFRDRX vs VFINX Comparison
Open Charts FRDRX vs VFINXBanner chart's image
Franklin Rising Dividends R
Price$89.32
Change-$7.48 (-7.73%)
VolumeN/A
CapitalizationN/A
Vanguard 500 Index Investor
Price$548.83
Change+$5.93 (+1.09%)
VolumeN/A
CapitalizationN/A
FRDRX vs VFINX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FRDRX vs. VFINX commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FRDRX is a Buy and VFINX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VFINX has more cash in the bank: 1.37T vs. FRDRX (25.5B). VFINX pays higher dividends than FRDRX: VFINX (1.24) vs FRDRX (0.67). FRDRX was incepted earlier than VFINX: FRDRX (23 years) vs VFINX (48 years). VFINX is a more actively managed with annual turnover of: 2.00 vs. FRDRX (1.88). VFINX has a lower initial minimum investment than FRDRX: VFINX (0) vs FRDRX (1000). VFINX annual gain was more profitable for investors over the last year : 25.40 vs. FRDRX (2.74). VFINX return over 5 years is better than : 84.83 vs. FRDRX (30.98).
FRDRXVFINXFRDRX / VFINX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years48 years-
Gain YTD1.89124.7638%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets25.5B1.37T2%
Annual Yield % from dividends0.671.2454%
Returns for 1 year2.7425.4011%
Returns for 3 years-3.3628.04-12%
Returns for 5 years30.9884.8337%
Returns for 10 years74.00186.1940%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XERS3.490.08
+2.35%
Xeris Biopharma Holdings
OWL23.490.39
+1.69%
Blue Owl Capital
HLMN9.96-0.04
-0.40%
Hillman Solutions Corp
APVO4.41-0.12
-2.65%
Aptevo Therapeutics Inc
HLP1.34-0.05
-3.60%
Hongli Group